ScholarIQanswers from OpenAlex & ORCID
Jami Kinnucan
ResearcherPublications, citations & collaboration network
Jami Kinnucan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jami Kinnucan have?
ScholarIQindexed works
Jami Kinnucan has 118 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jami Kinnucan have?
ScholarIQcitation count
Jami Kinnucan has 1,086 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jami Kinnucan?
ScholarIQh-index
Jami Kinnucan has an h-index of 12 in OpenAlex.
What is the i10-index of Jami Kinnucan?
ScholarIQi10-index
Jami Kinnucan has an i10-index of 18 in OpenAlex.
What is the ORCID of Jami Kinnucan?
ScholarIQorcid
The ORCID for Jami Kinnucan is on the source record.
What is the OpenAlex record for Jami Kinnucan?
ScholarIQopenalex
The OpenAlex for Jami Kinnucan is on the source record.
What are the most-cited papers on Jami Kinnucan?
ScholarIQmost cited works
Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case–Control Study
David T. Rubin, Dezheng Huo, Jami Kinnucan, Mina S. Sedrak, Nicole E. McCullom, Alana Bunnag, Elin P. Raun–Royer, Russell D. Cohen, Stephen B. Hanauer, John Hart, Jerrold R. Turner
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study
Jeffrey Berinstein, Jessica L. Sheehan, Michael Dias, Elliot Berinstein, Calen A. Steiner, Laura A. Johnson, Randolph E. Regal, John I. Allen, Kelly C. Cushing, Ryan W. Stidham, Shrinivas Bishu, Jami Kinnucan, Shirley Cohen‐Mekelburg, Akbar K. Waljee, Peter Higgins
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis
Jeffrey Berinstein, Calen A. Steiner, Randolph E. Regal, John I. Allen, Jami Kinnucan, Ryan W. Stidham, Akbar K. Waljee, Shrinivas Bishu, Leslie B. Aldrich, Peter Higgins
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
Britt Christensen, Dejan Micić, Peter G. Gibson, Andrés Yarur, Emanuelle Bellaguarda, Paul M. Corsello, John N. Gaetano, Jami Kinnucan, Vijaya L. Rao, S. Reddy, Siddharth Singh, Joel Pekow, David T. Rubin
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn’s Disease
Shrinivas Bishu, Mohamad El‐Zaatari, Atsushi Hayashi, Guoqing Hou, Nicole Bowers, Jami Kinnucan, Beth Manoogian, Michelle M. Muza–Moons, Min Zhang, Helmut Grasberger, Charlie Bourque, Weiping Zou, Peter Higgins, Jason R. Spence, Ryan W. Stidham, Nobuhiko Kamada, John Y. Kao